Invadopodia: A potential target for pancreatic cancer therapy

Crit Rev Oncol Hematol. 2021 Mar:159:103236. doi: 10.1016/j.critrevonc.2021.103236. Epub 2021 Jan 20.

Abstract

Dissemination of cancer cells is an intricate multistep process that represents the most deadly aspect of cancer. Cancer cells form F-actin-rich protrusions known as invadopodia to invade surrounding tissues, blood vessels and lymphatics. A number of studies have demonstrated the significant roles of invadopodia in cancer. Therefore, the specific cells and molecules involved in invadopodia activity can provide as therapeutic targets. In this review, we included a thorough overview of studies in invadopodia and discussed their functions in cancer metastasis. We then presented the specific cells and molecules involved in invadopodia activity in pancreatic cancer and analyzed their suitability to be effective therapeutic targets. Currently, drugs targeting invadopodia and relevant clinical trials are negligible. Here, we highlighted the significance of potential drugs and discussed future obstacles in implementing clinical trials. This review presents a new perspective on invadopodia-induced pancreatic cancer metastasis and may prosper the development of targeted therapeutics against pancreatic cancer.

Keywords: Invadopodia; Metastasis; Pancreatic cancer; Therapeutic targets.

Publication types

  • Review

MeSH terms

  • Cell Line, Tumor
  • Extracellular Matrix
  • Humans
  • Neoplasm Invasiveness
  • Pancreatic Neoplasms* / drug therapy
  • Podosomes*